0.00
—
Close of 4 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medican Enterprises
Its shares trade under the ticker MDCN. It has been listed since 22 May 2000. In the fiscal year to 31 December 2022, it reported revenue of $2.6m and net income of $6.4m. At that date it held total assets of $48.2m and shareholders' equity of $28.4m.
Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the production, cultivation, and wholesale distribution of cannabis related products. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2000-05-22. The firm is engaged in wholesale medical marijuana production, cultivation, and wholesale distribution of cannabis related products. Through joint ventures with development partners all over Canada and the United States, the Company builds and operates medical marijuana cultivation and research centers. The firm focuses on cultivating approximately five strains of cannabis, including High tetrahydrocannabinol (THC)/Low Cannabidiol (CBD), Medium THC/Low CBD, Medium THC/Medium CBD and Low TCH/High CBD. The firm provides strategic planning, valuation, project debt and corporate finance solutions to its joint venture partners in order to capitalize on the growing medical marijuana market and fund multiple facilities. The firm's subsidiary, Medican Systems Inc., is a licensed producer of medical marijuana under the new program marijuana for medical purposes regulation.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 22 May 2000
- Employees
- 3
Leadership
Pay as last reported
- Mr. Kenneth WilliamsChairman of the Board, Chief Executive Officer, since 2013$157,100
- Mr. Wayne HansenChief Financial Officer$93,925
- Mr. Michael ThompsonIndependent Director$38,170
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medican Enterprises Inc has a strong and experienced management team with extensive industry knowledge and connections. This enables the company to make informed decisions and seize lucrative opportunities in the market.
- The company also possesses advanced technological infrastructure and state-of-the-art facilities, providing a competitive edge in delivering high-quality products and services to its customers.
Weaknesses
- Medican Enterprises Inc faces certain weaknesses such as limited market share and brand recognition compared to its competitors. This may hinder its ability to attract new customers and expand its customer base.
- Furthermore, the company's heavy reliance on a single supplier for key raw materials poses a potential risk, as any disruptions or supply chain issues from the supplier could negatively impact operations.
Opportunities
- The growing demand for healthcare and medical services presents significant opportunities for Medican Enterprises Inc to expand its market presence and increase its customer base.
- Moreover, the increasing adoption of technology in the healthcare industry provides an opportunity for the company to develop innovative products and services that cater to the evolving needs of healthcare providers and patients.
Threats
- Medican Enterprises Inc faces threats from intense competition within the industry. Competitors may possess greater resources, market influence, and established customer relationships, making it challenging for the company to maintain or increase its market share.
- The company is also subject to various regulatory and compliance risks, which could result in legal implications and financial penalties if not effectively managed.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.